—
C+
C+ The full Closelook — membership. Open the C+ overview

Genus PLC (GNS.L) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Genus PLC

GNS.L in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Genus breeds and sells genetic material for farm animals, supplying semen, embryos and breeding stock to cattle and pig producers worldwide. It operates through three units — Genus PIC for pigs, Genus ABS for cattle, and a research arm that develops new genetic lines — and sells under its own and licensed brands. Customers span North America, Latin America, the UK, the rest of Europe, the Middle East, Russia, Africa and Asia, and the company is headquartered in Basingstoke, England.
Where it sits in the stack
Genus carries no seat in our index and sits outside the AI build-out stack the diary tracks; within our broader universe it falls under the healthcare sector, in the biotechnology and agricultural-genetics industry.
Who it is priced against
The diary has no peer group set for Genus. The market sometimes names Zoetis, an animal-health company, as a rough comparison, though neither name sits inside our AI-focused peer sets.
Why Closelook tracks it
Genus holds no seat in our index, carries no score, and has not appeared in our editions or quotes; the diary notes it only as a name that sits outside our AI coverage.
What the diary watches
The diary watches whether the shares' recent slide below their moving averages and further off their high stabilises or continues.

Genus PLC (GNS.L) trades on the LSE exchange in UK.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for GNS.L, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Biotechnology · 8 names with week and year-to-date

Peer group

Biotechnology

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against GNS.L on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 1.54%, semi-annual · last 10.44 GBP on 2025-12-29

Dividends and capital return

What GNS.L pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 32.14 GBP per share · a 1.54% yield on the 2026-09-18 close 2 distributions, paid twice a year 2026-09-18
  • Change on the year +212.1% against the prior twelve months prior twelve months 10.30 GBP per share
  • Last distribution 10.44 GBP per share as the price series records it, within days of the ex-date 2025-12-29
  • By calendar year 2025: 42.44 GBP (partial) first distribution recorded in the three-year window: 2025-03-06

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is Genus PLC (GNS.L)?

Genus PLC trades as GNS.L on the LSE exchange (UK) in the Closelook research universe, as of the registry build of 2026-09-19.

Is GNS.L in a Closelook index?

Not currently — Genus PLC is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

Where does GNS.L trade against its moving averages?

Downtrend stack: Trades -5.8% vs the 50-day and -15.5% vs the 200-day average, 35% below the 52-week high and +7.7% off the 52-week low. Computed from daily closes. As of 2026-09-18 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Genus PLC do?

Genus breeds and sells genetic material for farm animals, supplying semen, embryos and breeding stock to cattle and pig producers worldwide. It operates through three units — Genus PIC for pigs, Genus ABS for cattle, and a research arm that develops new genetic lines — and sells under its own and licensed brands. Customers span North America, Latin America, the UK, the rest of Europe, the Middle East, Russia, Africa and Asia, and the company is headquartered in Basingstoke, England. The diary has no peer group set for Genus. The market sometimes names Zoetis, an animal-health company, as a rough comparison, though neither name sits inside our AI-focused peer sets.

Where does Genus PLC sit in the AI build-out?

Genus carries no seat in our index and sits outside the AI build-out stack the diary tracks; within our broader universe it falls under the healthcare sector, in the biotechnology and agricultural-genetics industry. Genus holds no seat in our index, carries no score, and has not appeared in our editions or quotes; the diary notes it only as a name that sits outside our AI coverage.

Does Genus PLC pay a dividend?

Genus PLC has paid 32.14 GBP per share over the last twelve months, paid twice a year, a trailing yield of 1.54% on the 2026-09-18 close; the last distribution recorded in the price series was 10.44 GBP on 2025-12-29. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for GNS.L, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.